Literature DB >> 15771579

Antigen-specific memory B cell development.

Louise J McHeyzer-Williams1, Michael G McHeyzer-Williams.   

Abstract

Helper T (Th) cell-regulated B cell immunity progresses in an ordered cascade of cellular development that culminates in the production of antigen-specific memory B cells. The recognition of peptide MHC class II complexes on activated antigen-presenting cells is critical for effective Th cell selection, clonal expansion, and effector Th cell function development (Phase I). Cognate effector Th cell-B cell interactions then promote the development of either short-lived plasma cells (PCs) or germinal centers (GCs) (Phase II). These GCs expand, diversify, and select high-affinity variants of antigen-specific B cells for entry into the long-lived memory B cell compartment (Phase III). Upon antigen rechallenge, memory B cells rapidly expand and differentiate into PCs under the cognate control of memory Th cells (Phase IV). We review the cellular and molecular regulators of this dynamic process with emphasis on the multiple memory B cell fates that develop in vivo.

Mesh:

Substances:

Year:  2005        PMID: 15771579     DOI: 10.1146/annurev.immunol.23.021704.115732

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  276 in total

1.  Germinal center B cell and T follicular helper cell development initiates in the interfollicular zone.

Authors:  Steven M Kerfoot; Gur Yaari; Jaymin R Patel; Kody L Johnson; David G Gonzalez; Steven H Kleinstein; Ann M Haberman
Journal:  Immunity       Date:  2011-06-24       Impact factor: 31.745

Review 2.  Cell surface signaling molecules in the control of immune responses: a tide model.

Authors:  Yuwen Zhu; Sheng Yao; Lieping Chen
Journal:  Immunity       Date:  2011-04-22       Impact factor: 31.745

3.  Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction.

Authors:  James J Moon; Heikyung Suh; Adrienne V Li; Christian F Ockenhouse; Anjali Yadava; Darrell J Irvine
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-12       Impact factor: 11.205

4.  Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells.

Authors:  Simona Zompi; Brian H Santich; P Robert Beatty; Eva Harris
Journal:  J Immunol       Date:  2011-11-30       Impact factor: 5.422

Review 5.  POK/ZBTB proteins: an emerging family of proteins that regulate lymphoid development and function.

Authors:  Sung-Uk Lee; Takahiro Maeda
Journal:  Immunol Rev       Date:  2012-05       Impact factor: 12.988

6.  Antigen-specific antibody responses in B-1a and their relationship to natural immunity.

Authors:  Yang Yang; Eliver Eid Bou Ghosn; Leah E Cole; Tetyana V Obukhanych; Patricia Sadate-Ngatchou; Stefanie N Vogel; Leonard A Herzenberg; Leonore A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-14       Impact factor: 11.205

Review 7.  Roles of the NF-kappaB pathway in lymphocyte development and function.

Authors:  Steve Gerondakis; Ulrich Siebenlist
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-23       Impact factor: 10.005

Review 8.  Understanding the development and function of T follicular helper cells.

Authors:  Roza I Nurieva; Yeonseok Chung
Journal:  Cell Mol Immunol       Date:  2010-04-12       Impact factor: 11.530

9.  Human Extrafollicular CD4+ Th Cells Help Memory B Cells Produce Igs.

Authors:  Sang Taek Kim; Jin-Young Choi; Begona Lainez; Vincent P Schulz; David E Karas; Eric D Baum; Jennifer Setlur; Patrick G Gallagher; Joe Craft
Journal:  J Immunol       Date:  2018-07-20       Impact factor: 5.422

10.  Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccine.

Authors:  Dominic F Kelly; Matthew D Snape; Kirsten P Perrett; Elizabeth A Clutterbuck; Susan Lewis; Geraldine Blanchard Rohner; Meryl Jones; Ly-Mee Yu; Andrew J Pollard
Journal:  Immunology       Date:  2009-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.